The University of Chicago Header Logo

Connection

Blase Polite to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Blase Polite has written about Drug Resistance, Neoplasm.
Blase Polite
Connection Strength
0.114
Drug Resistance, Neoplasm
  1. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 04; 18(4):446-453.
    View in: PubMed
    Score: 0.098
  2. Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinoma. Clin Colorectal Cancer. 2010 Dec; 9(5):290-6.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.